The Ministry of Health recorded over 7,400 domestically-transmitted COVID-19 infections in Vietnam on Monday, together with more than 3,800 recoveries.
Thirty-eight provinces and cities reported 7,445 locally-infected patients while another 10 cases were imported from abroad, the health ministry said.
More than 2,300 cases were detected in the community whereas the remainder were found in isolated areas or centralized quarantine facilities.
Ho Chi Minh City recorded 4,264 of the latest domestic infections, Binh Duong Province 949, Long An Province 445, Dong Nai Province 380, Khanh Hoa Province 286, Can Tho City 221, Hanoi 159, and Ba Ria-Vung Tau Province 132.
Since the fourth COVID-19 wave began in Vietnam on April 27, the country has detected 157,919 community transmissions in 62 out of its 63 provinces and cities.
Ho Chi Minh City is taking the lead with 98,559 patients, followed by Binh Duong Province with 17,807, Long An Province with 6,457, Bac Ninh Province with 5,735, Dong Nai Province with 4,931, Dong Thap Province with 3,264, Tien Giang Province with 2,299, and Khanh Hoa Province with 2,294.
By comparison, Vietnam confirmed 106 community cases in the first wave from January 23 to April 16, 2020, 554 in the second from July 25 to December 1, 2020, and 910 in the third from January 28 to March 25, 2021.
The health ministry logged 3,808 recoveries on Monday, taking the total to 46,965 recovered patients.
The death toll has jumped to 1,695 after the ministry added 389 fatalities the same day, including 354 registered in Ho Chi Minh City from July 17 to August 2.
The Southeast Asian country has overall logged 159,489 domestic and 2,272 imported cases since the COVID-19 pandemic first hit it on January 23, 2020.
Health workers gave 209,156 vaccine doses today.
To date, over 6.4 million COVID-19 vaccine doses have been administered in Vietnam since the country rolled out vaccination on March 8, with 659,064 people having been fully vaccinated.
The Vietnamese government expects to obtain 175 million shots of various vaccines, including 51 million Pfizer-BioNTech jabs, by early 2022.
It set a target of immunizing two-thirds of a population of nearly 98 million people against COVID-19 by the first quarter of next year.